BioSpace News Archive

Business

ZOLL and Myant Enter Strategic Research and Development Collaboration

The LifeVest is worn by patients at risk of sudden cardiac death (SCD), providing protection during their changing condition and while permanent SCD risk has not been established.

November 28, 2017

·

5 min read

Drug Development

Maxwell Biotech Venture Fund’s Portfolio Company Hepatera LLC Announces Positive Interim Results of Phase IIb Clinical Program of Myrcludex B

After 24 weeks of treatment, Myrcludex demonstrated excellent safety profile with no drug-related SAEs or treatment discontinuations due to the study drug.

November 28, 2017

·

3 min read

Business

Tauriga Sciences and Group 10 Holdings LLC Reach Agreement to Fully Extinguish the $348,000 Assessed Liquidated Damage Total

The shares of common stock issued under the Agreement will be “restricted securities” as defined by the Securities Act of 1933, as amended.

November 28, 2017

·

4 min read

Business

YPB Group Ltd Agreement With Cellmid to Access Chinese Health Market

Brand protection and customer connection solutions company YPB Group Ltd and life sciences company Cellmid have signed an agreement to utilise the YPB CONNECT Consumer Connection SaaS platform in the marketing of Cellmid’s evolis hair loss products in China.

November 28, 2017

·

4 min read

Business

SYGNIS AG Signs Supply Agreement With U.S. Biological for the Lightning-Link Antibody Labelling Technology

The Company will use Lightning-Link as its preferred antibody conjugation technology to expand its existing catalogue by enabling the production of additional labels, and allowing the company to address a broader range of markets.

November 28, 2017

·

1 min read

BioMidwest

Turner Imaging Systems Announces Closing of Seed Investment Round

The round was led by venture capital firm Cavendish Impact Capital with participation from other private investors.

November 28, 2017

·

2 min read

Pharm Country

Chembio Diagnostics Awarded UNICEF Contract to Supply Point-of-Care DPP Zika Assays and DPP Micro Readers

The UNICEF LTA, which is valid through December 31, 2019, includes a firm purchase commitment of $1.5 million and possible additional purchases of up to $3.4 million, for a potential total amount of up to $4.9 million.

November 28, 2017

·

3 min read

Business

Skyline Medical and Helomics Announce a Joint Strategic Partnership With GLG Pharma

Companies to form a partnership for cell capture, culture and drug screening for ovarian and breast cancer patients.

November 28, 2017

·

8 min read

Drug Development

Athenex Announces Acceptance of Phase II Data of KX2-391 for the Treatment of Actinic Keratosis for Presentation at the American Academy of Dermatology Meeting on February 17, 2018

The abstract is entitled “Phase II Study of KX2-391 Ointment 1%, a Novel Field Treatment Based on Src/Tubulin Polymerization Inhibition, for Actinic Keratosis”.

November 28, 2017

·

3 min read

Policy

Agendia’s MammaPrint Breast Cancer Risk-of-Recurrence Test Obtains Favorable Final Payment Determination from CMS for New, Unique Category 1 CPT Code

Agendia announces that its MammaPrint 70-Gene Breast Cancer Risk-of-Recurrence Test has received a favorable payment determination for CY 2018 from the CMS for its new CPT code.

November 28, 2017

·

2 min read